Cyclacel Pharmaceuticals Dividends
| CYCC Stock | USD 13.25 2.14 13.91% |
The current year's Dividend Yield is expected to grow to 0.0004, whereas Dividends Paid is forecasted to decline to 0.00. Cyclacel Pharmaceuticals' past performance could be the main factor of why investors trade Cyclacel Pharmaceuticals stock today. Investors should clearly understand every aspect of the Cyclacel Pharmaceuticals dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Cyclacel Pharmaceuticals' dividend schedule and payout information. Cyclacel Pharmaceuticals dividends can also provide a clue to the current valuation of Cyclacel Pharmaceuticals.
| Last Reported | Projected for Next Year | ||
| Dividend Payout Ratio | (0.01) | (0.01) | |
| Dividend Paid And Capex Coverage Ratio | (70.05) | (73.55) |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Cyclacel Pharmaceuticals must own a stock before its ex-dividend date to receive its next dividend.
Cyclacel Pharmaceuticals Dividends Paid Over Time
Today, most investors in Cyclacel Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cyclacel Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Cyclacel Pharmaceuticals dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Cyclacel Pharmaceuticals Historical Dividend Yield Growth
A solid dividend growth pattern of Cyclacel Pharmaceuticals could indicate future dividend growth is likely, which can signal long-term profitability for Cyclacel Pharmaceuticals. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Cyclacel Pharmaceuticals dividend as a percentage of Cyclacel Pharmaceuticals stock price. Cyclacel Pharmaceuticals dividend yield is a measure of Cyclacel Pharmaceuticals stock productivity, which can be interpreted as interest rate earned on an Cyclacel Pharmaceuticals investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Cyclacel Pharmaceuticals Expected Dividend Income Per Share
Dividend payment represents part of Cyclacel Pharmaceuticals' profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in Cyclacel Pharmaceuticals. Cyclacel Pharmaceuticals' board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$0.04 Bottom Scenario | $0.05 | $0.06 Top Scenario |
One Year
Cyclacel Pharmaceuticals expected dividend income per share adjusted for ongoing price standard deviation
Cyclacel Pharmaceuticals Past Distributions to stockholders
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclacel Pharmaceuticals. If investors know Cyclacel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclacel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 41.45 | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
The market value of Cyclacel Pharmaceuticals is measured differently than its book value, which is the value of Cyclacel that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclacel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cyclacel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclacel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cyclacel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclacel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyclacel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclacel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.